Waterloo Capital L.P. lessened its stake in Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 58.9% during the fourth quarter, HoldingsChannel reports. The firm owned 8,957 shares of the company’s stock after selling 12,830 shares during the period. Waterloo Capital L.P.’s holdings in Keurig Dr Pepper were worth $288,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also bought and sold shares of the company. New Age Alpha Advisors LLC raised its stake in shares of Keurig Dr Pepper by 82.8% in the fourth quarter. New Age Alpha Advisors LLC now owns 859 shares of the company’s stock valued at $28,000 after buying an additional 389 shares during the period. LRI Investments LLC purchased a new stake in Keurig Dr Pepper in the 3rd quarter worth about $35,000. Whipplewood Advisors LLC bought a new stake in Keurig Dr Pepper in the 4th quarter valued at about $37,000. Edmond DE Rothschild Holding S.A. purchased a new stake in Keurig Dr Pepper during the fourth quarter valued at about $42,000. Finally, Brooklyn Investment Group boosted its position in Keurig Dr Pepper by 34.0% during the fourth quarter. Brooklyn Investment Group now owns 2,184 shares of the company’s stock worth $70,000 after purchasing an additional 554 shares during the period. Hedge funds and other institutional investors own 93.99% of the company’s stock.
Insider Transactions at Keurig Dr Pepper
In other news, VP Angela A. Stephens sold 7,350 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $34.17, for a total value of $251,149.50. Following the completion of the sale, the vice president now directly owns 74,587 shares in the company, valued at approximately $2,548,637.79. The trade was a 8.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Chairman Robert James Gamgort sold 416,000 shares of the company’s stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $34.29, for a total transaction of $14,264,640.00. Following the completion of the sale, the chairman now directly owns 3,237,066 shares of the company’s stock, valued at $110,998,993.14. This trade represents a 11.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 84,409,350 shares of company stock worth $2,756,709,930. 1.00% of the stock is currently owned by corporate insiders.
Keurig Dr Pepper Trading Down 0.6 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.01. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The firm had revenue of $4.07 billion for the quarter, compared to analysts’ expectations of $4.01 billion. During the same quarter last year, the company posted $0.55 EPS. The business’s quarterly revenue was up 5.2% on a year-over-year basis. Sell-side analysts forecast that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a yield of 2.74%. The ex-dividend date of this dividend is Friday, March 28th. Keurig Dr Pepper’s dividend payout ratio (DPR) is currently 87.62%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. TD Cowen lowered their price target on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a “hold” rating on the stock in a research report on Wednesday, January 8th. JPMorgan Chase & Co. increased their target price on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. UBS Group reiterated a “buy” rating on shares of Keurig Dr Pepper in a research report on Tuesday, February 25th. Barclays set a $39.00 target price on Keurig Dr Pepper in a research note on Thursday, February 27th. Finally, Wells Fargo & Company reiterated an “overweight” rating on shares of Keurig Dr Pepper in a research report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Keurig Dr Pepper presently has an average rating of “Moderate Buy” and an average price target of $38.38.
View Our Latest Report on Keurig Dr Pepper
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Recommended Stories
- Five stocks we like better than Keurig Dr Pepper
- Comparing and Trading High PE Ratio Stocks
- Options Activity Points to More Volatility for Palantir Stock
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- Stock Average Calculator
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Want to see what other hedge funds are holding KDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report).
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.